.png)
Lorem ipsum dolor sit amet, conse ● ctetur adipiscing elit, sed doLorem ipsum dolor sit amet, consectetur adipiscing el ● it, sed do Lorem ipsum dolor sit amet, conse ● ctetur adipiscing elit, sed doLorem ipsum dolor sit amet, consectetur adipiscing el ● it, sed doLorem ipsum dolor sit amet, conse ● ctetur adipiscing elit, sed doLorem ipsum dolor sit amet, consectetur adipiscing el ● it, sed do
Vision & Mission
Research Focus
The Peer’s lab works at the interface of materials science, chemistry, molecular biology, and immunology, aiming to discover and validate novel therapeutic targets at the molecular level, and to develop targeted genetic medicines for therapeutic applications and disease management. The lab is highly dynamic, multidisciplinary, focusing on developing targeted vehicles for cell-specific delivery of novel molecular medicines using RNAi , mRNA, saRNA, cirRNA, DNA, and novel genome editing strategies.
.png)
Innovation & Mentorship
The lab goal is to translate academic discoveries into innovative therapeutic modalities. With that in mind, Prof. Peer also founded SPARK Tel Aviv to accelerate cures via academic discoveries. Prof. Peer strives to develop the career of young students and encourage them to fulfill their ambitions and dreams.
Manuscripts
196
Citations
30,741
Patents
159
Wine Bottles
2,086
Active Research
Colon Targeting by Lipid Nanoparticles as a Platform for mRNA Therapeutics
Conformation-sensitive targeting of lipid nanoparticles for RNA therapeutics
mRNA-LNP Vaccine Provides Protection Against Bacterium
Genome editing approaches for in vivo gene therapy
ERC Project: Circular RNA Therapeutics for Duchenne Muscular Dystrophy
RNAs vaccines (mRNA, cirRNA, and saRNA)
Nano Moments, Mega Memories
Latest News
Standwithus • Amazing Israeli Innovation
Prof. Dan Peer was selected as Fellow of the National Academy of Inventors
Lior Stotsky- Oterin, Shmunis Excellence Scholarship 2025
Preeti Sharma, Ph.D.- 1st Prize- Best Student Poster Award, ICRS 2023
Israeli Researchers Develop mRNA Vaccine Against Antibiotic-Resistant Bacterium
